Risk-stratification models can help identify which hematopoietic cell transplant recipients are most likely to develop subsequent skin cancers, according to study results.The models demonstrated strong performance for predicting risks for basal cell carcinoma, squamous cell carcinoma and melanoma, findings published in JAMA Dermatology showed.